CN Stock MarketDetailed Quotes
002275 Guilin Sanjin Pharmaceutical
- 15.09
- +0.33+2.24%
Market Closed Dec 20 15:00 CST
8.87BMarket Cap21.71P/E (TTM)
15.09High14.64Low34.23KlotVolume14.75Open14.76Pre Close51.24MTurnover0.61%Turnover Ratio21.05P/E (Static)587.57MShares16.7452wk High3.09P/B8.44BFloat Cap10.7352wk Low16.24Limit Up559.04MShs Float32.69Historical High13.28Limit Down3.05%Amplitude4.46Historical Low0.55Dividend TTM14.97Avg Price12.75KlotAsk3.64%Div YieldTTM100Lot Size20.08KlotBid
Guilin Sanjin Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -1.31%1.75B | -8.14%1.23B | -11.44%505.61M | 13.51%2.44B | 17.96%1.77B | 36.40%1.34B | 6.35%570.93M | 12.53%2.15B | 18.22%1.5B | 8.81%983.17M |
| Refunds of taxes and levies | -96.54%140.85K | -96.54%140.85K | --140.85K | -85.88%4.33M | --4.07M | --4.07M | ---- | 89.96%30.67M | ---- | ---- |
| Cash received relating to other operating activities | 10.70%98.93M | -19.38%76.65M | -19.35%109.73M | -64.92%56.04M | 100.50%89.37M | 88.43%95.08M | 34.03%136.05M | -15.15%159.78M | -75.45%44.58M | -37.43%50.46M |
| Cash inflows from operating activities | -0.94%1.85B | -9.13%1.31B | -12.94%615.48M | 6.84%2.5B | 20.60%1.86B | 39.34%1.44B | 10.76%706.98M | 10.66%2.34B | 6.49%1.54B | 5.02%1.03B |
| Goods services cash paid | 14.35%564.07M | 6.85%462.9M | 187.23%253.21M | 0.24%523.2M | 17.86%493.3M | 68.42%433.23M | 16.40%88.16M | 14.17%521.94M | 93.14%418.55M | 65.32%257.23M |
| Staff behalf paid | 1.38%303.13M | 0.83%215.16M | -0.25%113.21M | 7.53%429.37M | 4.40%298.99M | 36.77%213.38M | -0.75%113.5M | 11.71%399.31M | 20.80%286.38M | -4.49%156.01M |
| All taxes paid | -26.73%210.28M | -40.70%144.32M | -35.86%75.14M | 39.35%393.45M | 36.91%286.99M | 150.08%243.37M | 61.79%117.15M | 6.89%282.34M | 5.16%209.61M | -29.41%97.32M |
| Cash paid relating to other operating activities | -3.45%534.22M | -21.50%282.98M | -55.42%148.87M | -0.52%600.96M | 43.65%553.28M | 14.92%360.48M | 60.50%333.94M | -2.94%604.08M | -23.88%385.17M | -4.17%313.67M |
| Cash outflows from operating activities | -1.28%1.61B | -11.61%1.11B | -9.55%590.43M | 7.71%1.95B | 25.61%1.63B | 51.71%1.25B | 38.72%652.75M | 6.26%1.81B | 12.13%1.3B | 5.12%824.23M |
| Net cash flows from operating activities | 1.45%233.79M | 7.16%203.32M | -53.81%25.05M | 3.89%549.25M | -5.95%230.44M | -9.38%189.75M | -67.67%54.24M | 28.87%528.67M | -15.94%245.02M | 4.66%209.39M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 61.16%380.37M | 102.38%296.39M | 577.47%98.23M | 1.20%652.65M | 391.72%236.03M | 388.17%146.45M | -27.50%14.5M | -45.40%644.89M | -86.01%48M | -3.23%30M |
| Cash received from returns on investments | 375.63%84.22M | 77.32%66.36M | -93.13%1.5M | -11.02%5.94M | -57.00%17.71M | 84.43%37.43M | 40.82%21.85M | -28.47%6.67M | 10.86%41.17M | -94.15%20.29M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 781.91%2.92M | 2,456.98%3.06M | -61.61%3.27M | 1,849.23%53.69M | 104.76%331.14K | 12.32%119.67K | -55.47%8.51M | -90.07%2.75M | -112.89%-6.96M | -99.80%106.55K |
| Cash received relating to other investing activities | -49.30%237.57M | -53.01%218.41M | 762,905.04%171.74M | -20.47%807.41M | -1.09%468.56M | -2.57%464.82M | -18.21%22.51K | 412.42%1.02B | 143.56%473.71M | 26.54%477.07M |
| Cash inflows from investing activities | -2.43%705.08M | -9.96%584.23M | 512.07%274.74M | -8.97%1.52B | 29.99%722.62M | 23.01%648.82M | -17.88%44.89M | 17.89%1.67B | -11.56%555.92M | -34.64%527.47M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -21.49%37.95M | -84.38%2.41M | -34.97%9.79M | 22.69%76.4M | 146.18%48.34M | 109.24%15.46M | -34.52%15.05M | -56.79%62.27M | -88.98%19.64M | -80.85%7.39M |
| Cash paid to acquire investments | 20.78%348M | 53.56%193.58M | 661.64%141.36M | 40.47%986.57M | 90.03%288.12M | 93.95%126.06M | -7.20%18.56M | -31.61%702.36M | 373.82%151.62M | -15.58%65M |
| Cash paid relating to other investing activities | -48.25%240.54M | -48.09%260M | 199.95%240M | -44.07%550.95M | -42.10%464.82M | -30.92%500.82M | -5.90%80.01M | 151.27%985.1M | 1,699.65%802.86M | -0.77%725.01M |
| Cash outflows from investing activities | -21.81%626.5M | -29.01%456M | 244.24%391.15M | -7.76%1.61B | -17.74%801.28M | -19.45%642.34M | -11.24%113.63M | 11.94%1.75B | 282.22%974.12M | -5.77%797.4M |
| Net cash flows from investing activities | 199.90%78.58M | 1,880.55%128.23M | -69.34%-116.41M | -17.42%-94.22M | 81.19%-78.66M | 102.40%6.47M | 6.30%-68.74M | 45.40%-80.24M | -211.89%-418.2M | -587.43%-269.93M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --83.98M | --83.98M |
| Cash from borrowing | 91.92%200M | 44.54%107.2M | -60.25%57.2M | 157.17%410.7M | --104.21M | 145.28%74.17M | 1,602.07%143.89M | -42.28%159.7M | ---- | -85.92%30.24M |
| Cash received relating to other financing activities | ---- | ---- | ---- | -24.21%63.74M | -58.33%76.02M | -32.61%62.9M | -60.28%33.36M | 68.21%84.1M | --182.41M | 256.50%93.35M |
| Cash inflows from financing activities | 10.97%200M | -21.79%107.2M | -67.73%57.2M | 94.60%474.44M | -32.35%180.23M | -33.96%137.07M | 91.76%177.25M | -25.37%243.8M | 27.04%266.4M | -13.84%207.56M |
| Borrowing repayment | 163.07%196.98M | 345.70%129.24M | 422.43%142.82M | 12.85%333.59M | 113.23%74.88M | 679.35%29M | -7.97%27.34M | 91.45%295.6M | -80.14%35.12M | -97.86%3.72M |
| Dividend interest payment | -22.66%193.58M | -23.24%193.58M | -47.89%14.96M | -25.07%427.77M | -24.97%250.29M | -14.22%252.18M | 3.01%28.71M | 25.83%570.88M | 36.72%333.59M | 21.82%293.99M |
| Cash payments relating to other financing activities | -83.23%4.98M | -66.29%5.5M | -81.71%955.02K | 24.20%74.65M | -59.24%29.72M | -32.92%16.32M | -76.94%5.22M | 56.22%60.1M | -13.85%72.92M | -53.21%24.32M |
| Cash outflows from financing activities | 11.46%395.55M | 10.36%328.32M | 159.07%158.74M | -9.78%836.01M | -19.64%354.88M | -7.62%297.49M | -23.63%61.27M | 43.31%926.59M | -12.64%441.62M | -31.12%322.04M |
| Net cash flows from financing activities | -11.96%-195.55M | -37.84%-221.12M | -187.56%-101.54M | 47.04%-361.57M | 0.33%-174.65M | -40.14%-160.42M | 850.10%115.98M | -113.44%-682.78M | 40.76%-175.22M | 49.48%-114.47M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -141.56%-608.92K | -89.27%196.54K | 105.07%98.31K | -89.60%864.97K | -86.55%1.47M | -66.36%1.83M | -22.23%-1.94M | 406.67%8.31M | 1,613.55%10.89M | 566.79%5.44M |
| Net increase in cash and cash equivalents | 642.95%116.22M | 193.98%110.63M | -293.70%-192.8M | 141.73%94.32M | 93.66%-21.41M | 122.19%37.63M | -5.23%99.53M | -280.99%-226.04M | -191.53%-337.51M | -153.18%-169.57M |
| Add:Begin period cash and cash equivalents | 10.10%850.29M | 1.51%783.91M | 10.10%850.29M | -24.69%689.59M | -30.78%772.25M | -30.78%772.25M | -47.74%772.25M | -6.09%915.63M | -18.08%1.12B | 14.43%1.12B |
| End period cash equivalent | 28.72%966.51M | 10.45%894.54M | -24.58%657.49M | 13.68%783.91M | -3.51%750.85M | -14.40%809.89M | -44.92%871.79M | -24.69%689.59M | -55.04%778.16M | 4.20%946.09M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
